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As medical specialties, Neurology, Psychiatry, and Clinical Genetics share manyaffinities, not only because 80% of the human genome is expressed in the centralnervous system, but also due to parallels in their history. Congenitalabnormalities and traumatic injuries causing neurobehavioral deficits allowed
drawing a map of the brain functional structure, beginning in the modern medicine with the
notorious report1 of Phineas Gage casualty in 1848 and the first publication of the cortical
cartography represented as a homunculus by Penfield and Boldrey2 in 1937.
In a similar way, translocations and unbalanced abnormalities seen in karyotype of
individuals with single gene disorders also allowed locus identification for type 1
neurofibromatosis (17q11.2), Duchenne muscular dystrophy (Xp21), Cornelia de Lange
syndrome (5p13.2), and many others. A first map of the human genome was published3 in
2001 and refined in the following years.
Besides, several chromosomal microdeletion and microduplication present with
characteristic neurobehavioral features, such as friendly loquacious personality in Williams
syndrome, obsession with eating, food related behavior, and unusual skill with jigsaw puzzle
in Prader-Willi syndrome, or polyembolokoilamania, onychotillomania, sleep disturbance,
and self-destructive behavior in Smith-Magenis syndrome. The 22q11 deletions in
velocardiofacial syndrome are frequently associated with schizophrenia4. Patients presenting
with these conditions, also denominated contiguous gene disorders, are frequently seen
by neurologists, psychiatrists, and clinical geneticists who independently or in interdiscip-
linary teams helped delineating the neurobehavioral phenotype and consensus diagnostic
criteria.
Mowat-Wilson syndrome (MWS) is another example of a condition reflecting these
medical specialties overlap. It was initially reported on six children, one of them presenting
with a chromosome 2q deletion5. In fact, MWS was later associated to heterozygous
mutations in the ZEB2 gene located in 2q22.3 which cause abnormalities in the neural crest
development resulting in deviant facial features, functional and structural defects of the
central nervous system (development delay, seizures, microcephaly, hypoplasia of the
corpus callosum), heart defects, and intestinal aganglionosis leading to Hirschsprung
disease6.
As in most developmental delay syndromes, MWS has been associated to a range of non
specific behavioral symptoms like hypotonia, marked delay in the motor milestones, learning
problems, moderate to severe intellectual deficiency, epilepsy, attention deficit disorder, and
autistic features, but a characteristic neuropsychological profile has also been proposed6.
Performance in MWS included sociable demeanor and happy affect with frequent laughs, a
high rate of oral behaviors (bruxism, chewing or mouthing objects or body parts), an
increased rate of repetitive behaviors, under-reaction to pain, and severely impaired or
absent speech with contrasting better receptive language7.
The 15 years following its original description revealed remarkable discoveries regarding
MWS physiopathology, molecular basis, inheritance, and phenotypic spectrum, but
diagnostic criteria and a precise incidence have not been defined yet. Half of the literature
on this condition was published in the last five years and the rate of publications on it
increases every year. Thus, the diagnosis of MWS must be considered by professionals that




In this issue, Paz et al.8 present the first series of Brazilian
patients diagnosed with MWS, adding new data to the
international literature. Seven individuals were diagnosed by
mutation analysis of the ZEB2 gene. Detailed information on
dysmorphologic and neurological examination, epileptic
history, electroencephalographic findings, Denver II scale
evaluation, and brain magnetic resonance imaging are
discussed.
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